Evaluation. Patients should have complete evaluations including contrast-enhanced computed tomography (CT) of the neck, chest, and abdomen, esophagogastroduodenoscopy (EGD), endoscopic ultrasound (EUS), whole-body fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT, and bronchoscopy for upper- and middle-third lesions. Upper gastrointestinal series (barium swallow) is recommended if EGD or EUS study is incomplete due to severe luminal obstruction. These studies help the treating physician in determining disease extension and allow accurate target volume delineation for esophageal cancer.
KeywordsEsophageal Cancer Planning Target Volume Clinical Target Volume Gross Tumor Volume Thoracic Esophagus
References and Suggested Reading
- Gao XS, Qiao X, Wu F, Cao L, Meng X, Dong Z, Wang X, Gao G, Wu TT, Komaki R et al (2007) Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys 67(2):389–396CrossRefPubMedGoogle Scholar
- Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC, Cheng JC (2011) Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 81(4):e593–e599CrossRefPubMedGoogle Scholar
- Kong FM, Quint L, Machtay M, Bradley J (2013) Atlases for organs at risk (OARs) in thoracic radiation therapy. http://www.rtog.org/CoreLab/ContouringAtlases/LungAtlas.aspx